Article
BRAF V600E and previously unidentified KRAS G12C mutations in odontogenic tumors may affect MAPK activation differently depending on tumor type.
Genes, chromosomes & cancer - 1 Aug 2022
Oh Kyu-Young, Kim Ji-Hoon, Cho Sung-Dae, Yoon Hye-Jung, Lee Jae-Il, Hong Seong-Doo
Abstract excerpt
Although several types of odontogenic tumors share the same mutations in MAPK pathway genes, their effects on MAPK activation remain unclarified. This study aimed to evaluate the associations between these mutations and ERK phosphorylation in ameloblastoma and mixed odontogenic tumors (MOTs) and to analyze the expression pattern of phosphorylated ERK (p-ERK) for determining the involvement of MAPK activation in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
